Magnesium sulphate as a first line therapy in the management of tetanus

Anaesthesia

Volumn 58, Issue 3, 2003, Pages 286-

  Thwaites, C L ^a   Farrar, J J ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG USE; HUMAN; HYPOTENSION; LETTER; LUNG VENTILATION; MORTALITY; MUSCLE SPASM; MUSCLE WEAKNESS; PARALYSIS; PRIMARY HEALTH CARE; RISK; TETANUS;

EID: 0037342321     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2003.30568.x     Document Type: Letter

References (4)

1. Williams S. Use of magnesium to treat tetanus. British Journal of Anaesthesia 2001; 88: 152.
2. Attygalle D, Rodrigo N. Magnesium sulphate for control of spasms in severe tetanus. Can we avoid sedation and artificial ventilation? Anaesthesia 1997; 52: 956-62.
3. James MF, Manson ED. The use of magnesium sulphate infusions in the management of very severe tetanus. Intensive Care Medicine 1985; 11: 5-12.
4. James MF. Magnesium sulphate for the control of spasms in severe tetanus. Anaesthesia 1998; 53: 605-6.